Janumet 50-500mg pill is a combination medicine used for the treatment of type 2 diabetes mellitus. Patients are advised to maintain a strict exercise and diet regimen along with this pill to get the best possible effect. This pill is not recommended for use in patients below 18 years of age.
Take the missed dose as soon as you remember. If it is almost time for your ensuing dose, skip the missed dose. Do not double your dose to make up for the missed one.
Seek emergency medical nursing or contact the doctor in case of an overdose.
How Janumet Works
Janumet pill contains two active ingredients, sitagliptin (as phosphate monohydrate) and metformin hydrochloride. Sitagliptin belongs to a class of pills called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), and metformin belongs to a class of pills called biguanides. Sitagliptin and metformin work together to control blood sugar levels in patients with type 2 diabetes mellitus.
How to use Janumet
Take this pill by mouth as directed by your doctor, usually twice a day with meals. Drink plenty of fluids while taking this pill unless otherwise directed by your doctor. The manufacturer directs not to split/break/cut the tablet before taking it. However, many similar pills (immediate-release tablets) can be split/cut. Follow your doctor’s directions on how to take this medication.
Side Effects of Janumet
Tell your doctor if any of the following side effects become severe or don’t go away:
- Mild nausea, diarrhea, constipation, or upset stomach
- Metallic taste in the mouth
- Back pain
- Joint or muscle pain
- Cold symptoms, such as sneezing, runny nose, or sore throat
This pill is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this pill.
This pill is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this pill. Your doctor may prescribe a safer optional based on your clinical condition.
Use in children
This pill is not recommended for use in children and adolescents since the safety and efficacy of use are not clinically established.
This pill should be used with caution due to the increased risk of bullous pemphigoid, a hypersensitivity reaction of the skin. Any unusual symptoms such as skin blisters or skin rashes should be reported to the doctor on priority. Therapy with the pill may be discontinued based on the clinical condition of the patient.
This pill is not recommended for use in patients with a known history of diabetic ketoacidosis due to the increased risk of worsening of the patient’s condition.
Type 1 diabetes mellitus
This pill is not recommended for use in patients with type 1 diabetes mellitus.
This pill may cause lactic acidosis, which may be fatal, in some patients. This risk is especially higher in patients suffering from heart diseases, kidney diseases, etc. Report any unusual symptoms to the doctor immediate. Replacement with a suitable optional may be required based on the clinical condition.